As a Data Scientist at KARL STORZ, you will play a pivotal role in transforming complex data into actionable insights that directly impact medical device development and operational efficiency. This position is critical as it not only influences product innovation but also enhances patient outcomes through data-driven decision-making. By leveraging statistical analysis, machine learning, and domain expertise, you will contribute to projects that span various areas, including surgical instruments and minimally invasive procedures.
The work you do will help shape the future of medical technology, making it more efficient and effective. You will collaborate closely with cross-functional teams, including engineering, product management, and clinical affairs, to drive projects that improve the usability and performance of our products. The complexity and scale of data you will handle, combined with the strategic influence of your insights, make this role both challenging and rewarding.
Hiring Manager Interview
reportedThis conversation decides whether you can be handed a problem nobody has finished defining and left alone with it for a few weeks. The manager is listening for how you behave when the brief is thin: what you clarify before starting, and what you settle on your own rather than escalating. Most candidates over-index on technical depth here and under-describe the decisions they actually owned. Say who wanted the work, what you chose not to do, and where you would have stopped and asked. A clean account of your own judgement carries this round further than a longer project list.
What to demonstrate
- Whether you can name a decision that was yours alone, as opposed to one the team arrived at
- How you respond to a request that arrives with no success metric attached to it
- Whether the effort you estimate for a piece of work matches the work you just described doing
- What you escalate, and how long you sit on a problem before you do
How to prepare
- For each project you plan to raise, write one sentence saying what would not have happened if you had not been on it, and check that the sentence is about an outcome rather than an artefact
- List the decisions in your last project that were genuinely yours, and for each one write down the option you rejected and why
- Prepare the project that went badly: the point at which you knew, who you told, and what it cost before it was caught
Behavioral Interviews
reportedRounds of this kind usually include one question about work that did not go well, and it is the part that carries the most information. Anyone can narrate a shipped win. What the interviewer learns from a project that stalled is how you behave without a result to hide behind: whether you noticed the problem yourself, how long it took, and who you told. Answers that route the failure onto a data pipeline or a reorganisation close the topic without answering it, and the follow-up comes back to your own part.
What to demonstrate
- Whether you found the error yourself or someone else found it, and how long it sat before anyone knew
- What you changed afterwards, stated as a check you now run rather than a lesson you now believe
- Whether the mistake you choose has real cost attached, such as a quarter of misdirected roadmap or a metric that was reported upward, instead of one that flatters you
How to prepare
- Choose a failure you caught yourself and be ready to say what tipped you off. A story where someone else caught it is still usable, but you will be asked why you missed it.
- Write down the check you added afterwards and where it lives now, so the correction is a concrete artefact rather than a resolution.
- Rehearse saying the cost out loud. Candidates shrink the number by instinct once the interviewer is in the room.
PracHub editorial advice for the preparation topics above.
Reading the most recent months of a claims-based series as real
Claims incur before they are reported and paid, so recent incurred months are systematically undercounted until runout completes. The lag is not uniform: pharmacy adjudicates in days, professional claims in weeks, inpatient facility claims in months. That means recent data is both too low and mix-shifted toward cheap services, which reads as a cost improvement and a utilisation drop at once. The fix is to hold the last three incurred months back or apply completion factors, and to state the paid-through date on every chart.
Ignoring clustering by provider, facility, or site
Patients within a provider panel, and subjects within a trial site, are correlated on both case mix and practice pattern. Standard errors computed as if observations were independent are too narrow by roughly the design effect, 1 + (m - 1) * ICC, where m is the average cluster size. With 50 patients per provider and an intracluster correlation of only 0.02, variance is understated by about a factor of two, which manufactures significant provider differences out of noise. Cluster-robust errors or a random intercept per provider, and cluster-level randomisation when you design the test, are the corrections.
Reading a dozen metrics with no multiplicity control
Nominate one primary metric before launch and treat the rest as guardrails or exploratory, with Bonferroni or Benjamini-Hochberg applied when you intend to make claims from them. Twenty independent tests at 0.05 under the null produce at least one false positive about 64 percent of the time.
Naming a model class before naming the deployment constraints
Set out the latency budget, the label delay, the retraining cadence, the interpretability requirement and the number of labelled examples, then pick the model that fits them. A boosted-tree answer to a problem where each decision must be explained to the affected user is a well-executed answer to the wrong question.
Choose a category, try a prompt, then open its approach, worked solution or follow-up when you need it.
How do you approach feature selection when building a predictive model…
How do you approach feature selection when building a predictive model?
Approach
- Frame the prediction: the label, the moment of prediction, and the action it triggers.
- Say how the offline result would be validated online before it is trusted.
- Pick an evaluation metric that matches the cost of each error type, not a default.
Follow-up
- What would you monitor after launch to know the model is still valid?
- How would you choose the decision threshold, and who owns that choice?
Expand overlapping coverage spans into fractional member-months
member_enrollment has span_id, member_id, plan_id, product_type, effective_date, termination_date (NULL while active). Both dates are inclusive. Write a function returning one row per calendar month of a stated year with total member-months, where a member contributes covered days in the month divided by days in that month, capped at one month per member even when two spans overlap after a plan change or a retroactive span. Do not expand to one row per member-day: the sample has 400,000 members. Output: month, member_months.
Approach
- Resolve NULL termination_date to the reporting end date and say so in a comment. An open span is not an infinite span, and clipping it at the year end is what keeps the denominator finite and auditable.
- Merge overlapping and adjacent spans per member before touching months. Sort by member_id and effective_date, carry a running maximum of the end date, and open a new merged group when effective_date exceeds that running max plus one day. Adjacent means a gap of zero days, which a plan change produces constantly.
- Cross join the merged spans to the 12 month boundaries rather than to days. Overlap days = (min(span_end, month_end) - max(span_start, month_start)).days + 1, clipped below at 0. That is at most 12 rows per span instead of 365.
- Divide overlap days by the number of days in that month, so February and July are weighted correctly, then sum by month.
- Validate on a constructed member before trusting the aggregate: a single span covering the whole year must sum to exactly 12.0.
Worked solution 30 min
- Fill termination_date nulls with the reporting end date and clip all spans to the reporting year.
- Sort by member_id, effective_date, then compute a running max end per member with cummax shifted by one, flag a new group where effective_date > prior_max_end + 1 day, and cumsum the flag to get merged group ids.
- Aggregate each group to min start and max end, producing disjoint spans per member.
- Cross join merged spans to a 12-row month frame, compute clipped overlap days, divide by days in month.
- Group by month and sum.
Follow-up
- Product type changes mid-year. The metric must be reported by product_type. Where does the cap now apply and what breaks?
- An eligibility file arrives with a retroactive termination that shortens a span you already reported on. How do you restate?
- Why member-months rather than distinct members, in one sentence, for a director who wants the simpler number?
Simulate how ignoring clustering inflates the false positive rate
Simulate a provider-level comparison with no true effect. 40 providers, 60 members each, a continuous outcome with total variance 1 and intraclass correlation 0.02. Randomise providers 20 to 20, not members. Over 5,000 replications, report the share of replications where a two-sample t-test run on all 2,400 individual observations, ignoring provider, returns p below 0.05. Report the same share when the unit of analysis is the 40 provider means. Then state how the first number follows from the design effect 1 + (m - 1) x ICC.
Approach
- Decompose the variance explicitly rather than tuning it: provider variance = ICC = 0.02, residual variance = 1 - ICC = 0.98. Draw u_j once per provider and e_ij per member, so the outcome is u_j + e_ij and the correlation between two members of one provider is 0.02 by construction.
- Randomise at the provider level. That is the entire mechanism: the treatment indicator is constant within a provider, so in any single replicate the provider intercepts are confounded with the arm, and the naive test reads that confounding as signal.
- Vectorise over replications with a (reps, providers, members) array. 5,000 x 2,400 normals is trivial in numpy, and a Python loop is what tempts people to cut replications to 500 and report a number with Monte Carlo noise of plus or minus 0.017.
- Predict the answer before running it: design effect = 1 + (60 - 1) x 0.02 = 2.18, naive standard errors are too small by sqrt(2.18) = 1.476, so the rejection rate at nominal 0.05 is about 2 x (1 - Phi(1.96 / 1.476)) = 0.18. Agreement between prediction and simulation is what makes the result a demonstration rather than an anecdote.
- Run the provider-mean analysis as the control. Recovering 0.05 there proves the generator is correct and isolates the failure to the analysis unit.
Follow-up
- How many providers would you need for 80 percent power on a 0.2 SD difference with 60 members each and this ICC?
- Cluster sizes are unequal in reality. The design effect approximation becomes 1 + ((1 + CV^2) x mbar - 1) x ICC. Which direction does that move your sample size and why?
- The intervention cannot be withheld from any provider. Sketch a design that still yields a defensible estimate.
Find inpatient encounters with no resulted lab during the stay
encounter holds encounter_id, patient_id, encounter_type, admit_ts, discharge_ts and facility_id. lab_result holds result_id, order_id, patient_id, encounter_id (NULL for outpatient standing orders), loinc_code, specimen_collected_ts, resulted_ts and result_status. Return every inpatient encounter discharged in 2025 with no final or corrected lab_result linked to it. A colleague wrote WHERE encounter_id NOT IN (SELECT encounter_id FROM lab_result) and got zero rows back. Say why, write the correct query, then say what changes when labs must instead be matched on patient_id with the specimen collected between admit_ts and discharge_ts.
Approach
- Name the mechanism rather than the symptom. x NOT IN (subquery) expands to x <> y1 AND x <> y2 AND ..., and a single NULL y makes that chain UNKNOWN, never TRUE. Since lab_result.encounter_id is nullable by design for standing orders, this query can only ever return zero rows.
- Rewrite as NOT EXISTS, or LEFT JOIN with an IS NULL filter. Both treat a NULL key as no match rather than as unknown. Adding IS NOT NULL inside the NOT IN subquery also works, but NOT EXISTS is the habit that survives someone making another column nullable later.
- Put the result_status predicate inside the correlated subquery or the ON clause, not in an outer WHERE. Outside, it turns the anti-join back into an inner join and an encounter whose only labs were cancelled disappears instead of qualifying.
- For the timestamp variant, match on patient_id with specimen_collected_ts inside the stay rather than resulted_ts. A specimen drawn an hour before discharge can result the next day, and anchoring on resulted_ts would wrongly call that stay lab-free.
- Restrict to encounter_type 'inpatient' and discharge_ts in 2025, and report open encounters with a NULL discharge_ts as a separate count instead of letting the filter swallow them.
Follow-up
- Write the LEFT JOIN form and say exactly where the result_status predicate must sit for the two forms to agree.
- How would you separate encounters whose only labs were cancelled from encounters with no lab rows at all?
- Some encounters carry member_id NULL because the person index did not match. What does that do to a payer-side version of this measure?
Count thirty-day unplanned readmissions without counting transfers
encounter holds encounter_id, patient_id, facility_id, encounter_type, admit_ts, discharge_ts, admission_type, discharge_disposition, is_planned_admission and index_encounter_id. For inpatient stays discharged between 2025-01-01 and 2025-11-30, return the 30-day unplanned readmission rate overall and by facility_id. Exclude an index stay when is_planned_admission is TRUE or discharge_disposition is transfer_acute, expired, hospice or ama. A qualifying readmission is any unplanned inpatient admission for the same patient with admit_ts after the index discharge_ts and within 30 days of it. One stay can be both a readmission and the next index stay.
Approach
- Decide between LEAD and EXISTS explicitly and say why. LEAD over the patient's admission stream gives the literal next stay, so an intervening planned admission hides a later unplanned one. The measure asks whether any unplanned admission fell in the window, which is an EXISTS or a self-join with a range predicate.
- Exclude transfers at the index end before anything else. An acute-to-acute transfer closes one encounter and opens another at a different facility_id within hours, so without the transfer_acute exclusion the facilities that move the sickest patients out look the worst.
- Apply the index exclusions as a set, including stays with NULL discharge_ts, which are still open and have no measurable window.
- Stop the denominator early enough that every index stay had a full 30 days of observation plus encounter lag. That is why the window ends 2025-11-30 rather than at year end.
- Compute the rate at stay level, not patient level, then compare the raw facility rates against an observed-over-expected framing before anyone publishes a ranking.
Worked solution 30 min
- CTE ip: inpatient encounters with a non-null discharge_ts.
- CTE index_stays: ip rows with discharge_ts in the window, is_planned_admission FALSE, and discharge_disposition not in the four excluded values.
- Flag each index stay with EXISTS against ip for the same patient_id where is_planned_admission is FALSE, encounter_id differs, admit_ts > index.discharge_ts and admit_ts <= index.discharge_ts + 30 days.
- Aggregate numerator and denominator overall and grouped by facility_id.
- Re-run with the transfer exclusion removed and record how much the rate moves.
Follow-up
- A patient has three stays ten days apart. How many index stays and how many readmissions, and why does the answer depend on the stated rule?
- Which comparison would you publish across facilities, raw rate or observed over expected, and what does risk adjustment still fail to fix?
- index_encounter_id already exists on the table. Would you trust it, and how would you audit it against your own logic?
If tasked with optimizing a surgical device based on user feedback dat…
If tasked with optimizing a surgical device based on user feedback data, what steps would you take?
Approach
- State what result would change your recommendation, so the answer is falsifiable.
- Name one primary metric, then the guardrail that stops it being gamed.
- Restate the decision this analysis has to support, and who acts on the answer.
Follow-up
- What would you do if the primary metric and the guardrail moved in opposite directions?
- How would you detect that the metric is being gamed rather than genuinely improving?
Discuss how you would approach a project aimed at reducing post-operat…
Discuss how you would approach a project aimed at reducing post-operative complications through data analysis.
Approach
- Fix the population and the time window before naming any metric.
- State what result would change your recommendation, so the answer is falsifiable.
- Name one primary metric, then the guardrail that stops it being gamed.
Follow-up
- Which segment would you cut first, and what would that rule out?
- What would you do if the primary metric and the guardrail moved in opposite directions?
Given a dataset with missing values, how would you proceed with your a…
Given a dataset with missing values, how would you proceed with your analysis?
Approach
- Restate the decision this analysis has to support, and who acts on the answer.
- Fix the population and the time window before naming any metric.
- Decompose the metric into the rates that drive it, and say which one you would check first.
Follow-up
- What would you do if the primary metric and the guardrail moved in opposite directions?
- Which segment would you cut first, and what would that rule out?
Discuss a project where you had to work with messy data. What strategi…
Discuss a project where you had to work with messy data. What strategies did you employ to clean it?
Approach
- Work from the decision backwards to the evidence you would need.
- Clarify what is being asked and what a complete answer would contain.
- Say what you would check first and why it is the highest-information step.
Follow-up
- What assumption would you test first?
- How would you know your answer was wrong?
Can you explain the difference between supervised and unsupervised lea…
Can you explain the difference between supervised and unsupervised learning?
Approach
- Work from the decision backwards to the evidence you would need.
- Clarify what is being asked and what a complete answer would contain.
- Say what you would check first and why it is the highest-information step.
Follow-up
- How would you know your answer was wrong?
- What assumption would you test first?
Evaluate a book-wide benefit change with no untreated members
On 1 January a therapeutic class moves from formulary tier 2 to tier 3, raising member cost share, for the entire commercial group book at once. No untreated subset of that book exists. You have 36 months of pharmacy_claim and member_enrollment covering that book plus the Medicare Advantage and Medicaid managed books, which are unaffected. Outcomes are class fills per 1,000 member-months and the share of members with PDC at or above 0.80. Give the design, the identifying assumption, and how you would test it.
Approach
- Rule out the single-series interrupted time series first and say why. The change lands on 1 January, which is also when deductibles reset, benefit designs change, and members switch plans, so a level shift at the new year is confounded with the entire annual benefit cycle. Any design that cannot separate those two is not usable here.
- Build an event-study difference-in-differences with the unaffected product books as controls, estimating month-by-month coefficients relative to December. The lead coefficients are the test of the identifying assumption, not decoration: they should be indistinguishable from zero, and you should say in advance what magnitude of lead violation would make you abandon the design.
- State what the control books are doing for you and what they are not. They experience the same January reset, which is precisely why they are useful, but they differ in population age, cost-sharing structure, and eligibility churn, so parallel counterfactual trends is a real assumption and residual confounding should be named rather than waved at.
- Add a synthetic control as the robustness check: construct a weighted combination of donor series (other product books crossed with other therapeutic classes) that tracks the treated series through the pre-period, and do inference by permutation, assigning the intervention to each donor and comparing post-to-pre RMSPE ratios. Require that the treated pre-period sits inside the convex hull of the donors, and abandon the approach if pre-period fit is poor.
- Fix the population before estimating anything. If the tier move pushes members out of the book, the post-period population differs from the pre-period one, so restrict to members continuously enrolled across the window with a stated allowable gap, and report sensitivity to that gap. Note that pharmacy claims adjudicate in days, so unlike a medical-cost series this outcome is essentially complete within weeks.
Worked solution 45 min
- Build a monthly panel of fills per 1,000 member-months and PDC share by product book, restricted to members continuously enrolled across the window with a 45-day allowable gap.
- Plot the treated and control series for 24 pre-period months and inspect visually before fitting anything.
- Estimate an event-study DiD with month-relative-to-January coefficients, product fixed effects, and calendar-month fixed effects, clustering standard errors at the product-book level or higher.
- Run the placebo: re-estimate as if the change happened on the prior 1 January, which isolates the annual reset from the tier move.
- Fit a synthetic control on donor product-class series, check pre-period RMSPE, and run the permutation inference across donors.
Follow-up
- The lead coefficients are not flat: the treated book was already drifting down for six months. What do you do without abandoning the question?
- Therapeutic substitution is expected. How do you tell a true reduction in therapy from members moving to a cheaper drug in the same class?
- How would you report the result so a clinical committee can act on it, given that fills per 1,000 member-months is not an outcome anyone treats?
First-pass denial rate doubled in one received week
First-pass denial rate jumped from 6.1 to 11.8 percent in a single received_date week and stayed at the new level. Nothing in the adjudication rules changed that week. You have medical_claim_line: claim_id, claim_version, frequency_code, claim_status, denial_reason_code, member_id, received_date, adjudicated_at, billing_provider_npi. The metric counts lines whose first adjudication returns 'denied', over lines received in the window at claim_version = 1. Find the cause, say whether denial behaviour actually changed, and deliver the corrected series plus the query change that fixes it.
Approach
- Cut the excess by denial_reason_code before anything else. A behaviour change spreads across codes; an upstream failure concentrates in one. If a single eligibility-related code carries nearly all of the 5.7 point excess, the claims are fine and the eligibility data was not.
- Join the denied lines to member_enrollment and compare the span's created_at to the claim's received_date. Lines denied for members whose coverage span loaded after the claim arrived are a load-ordering failure, not a coding failure.
- Check resolution downstream: take those claim_ids and look for a later version with frequency_code 7 that adjudicates to 'paid'. A high resubmit-and-pay share confirms the denial was transient and recoverable.
- Verify the denominator is not the mover. Count lines at claim_version = 1 by received_date and check the weekday mix, because submission batching makes received_date strongly day-of-week patterned and a short or holiday week shifts the denominator without changing behaviour.
- Confirm runout: the metric should be held until 60 days of adjudication have passed, so check that the comparison weeks are equally mature rather than comparing a settled week to a fresh one.
- Restate the series with the affected reason code broken out as its own line, and change the query to carry denial_reason_code into the reported breakdown rather than only the headline rate.
Follow-up
- The affected lines all get paid on resubmission. Is the first-pass denial rate then wrong, or right and uninteresting?
- How would you monitor for this class of failure without waiting for someone to notice a chart?
- What changes if the excess is spread evenly across denial_reason_code instead of concentrated?
Instead of guessing where the week should go, day one measures it under a fixed rubric and allocates the remaining hours in proportion to the gaps. The method is deliberately rigid: the allocation is written down before any studying starts and is not renegotiated when a topic turns out to be unpleasant.
Prepare, practise & reflect
One practical outcome each day. Spend longer where you need it.
0 / 7 done01Diagnostic, scored before you study anything
- Sit a 100-minute timed diagnostic in four blocks: 30 minutes of SQL across three prompts, 25 minutes of short-answer statistics, 25 minutes on one modelling or case prompt, and 20 minutes delivering one behavioural story aloud.
- Score each block from 0 to 3 on a fixed rubric where 3 is correct and fluent, 2 is correct but slow or prompted, 1 is partially correct, and 0 is stuck, grading the output rather than how the attempt felt.
- Allocate the hours for days two to five roughly in proportion to 3 minus the score in each block, write the allocation down, and commit to not revising it midweek.
Deliverable: A scored rubric and a fixed hour allocation for the rest of the week.
Practice prompt ↗Practice prompt ↗Practice prompt ↗Worked solution ↗02Largest gap: find the boundary rather than the subject
- Break the weakest area into five named sub-skills (for query work: grain control, window frames, date arithmetic, set logic with NULLs, and reading a query plan) and rate each one, so the rest of the week targets a sub-skill instead of a subject.
- Solve three problems chosen to sit just above where the rating drops off, and for each write the first move you failed to make.
- Re-solve one of them from memory four hours later, on paper, with nothing open.
Deliverable: A five-item sub-skill map with the two blocking sub-skills circled.
Practice prompt ↗Practice prompt ↗03Largest gap: drill the blocking sub-skill
- Do eight short repetitions of the same shape rather than eight different problems, so what you practise is the pattern and not the puzzle.
- Write the rule you now hold in one sentence, then test it against a case built to break it: a ranking function over a column with ties, or a two-sample test on observations that are obviously dependent.
- Have someone else read your one-sentence rule and find the precondition you left out.
Deliverable: One rule statement with its preconditions attached and one counterexample that would have caught the incomplete version.
Practice prompt ↗Practice prompt ↗04Second gap, plus maintenance on your strongest area
- Run the same sub-skill map and boundary protocol on the second-largest gap, compressed into half the day.
- Spend 25 timed minutes on your strongest area to stop it decaying, choosing the hardest problem you can still finish rather than an easy warm-up.
- Compare how the two areas fail: whether you lose time on recall, on setup, or on arithmetic, because the fix differs for each.
Deliverable: A second sub-skill map plus a one-line diagnosis of how each area fails you.
Practice prompt ↗Practice prompt ↗Worked solution ↗05The gap that is not a skill
- Record yourself answering one technical and one behavioural prompt, then count two things in the playback: how many seconds before your first clarifying question, and how many sentences you started without knowing where they ended.
- Rewrite your three most-used stock phrases into shorter versions, and practise saying "I do not know, here is how I would find out" without softening it into a guess.
- Deliver one answer again with a hard 90-second limit to force structure before detail.
Deliverable: Two recordings with a counted improvement in time-to-first-question.
Practice prompt ↗Practice prompt ↗06Retest under day-one conditions
- Sit the same 100-minute diagnostic structure with new prompts of comparable difficulty and score it on the identical rubric.
- Compare block by block, and for any block that did not move, change the method rather than adding hours: a block stuck at 1 usually means the practice was too varied, not too short.
- Write which single block you would still lose the offer on.
Deliverable: A second scored rubric placed next to the first, with one named remaining risk.
Practice prompt ↗Practice prompt ↗07Full loop under interview conditions
- Run a 60-minute mock covering the two blocks that moved least, with an interviewer instructed to interrupt and change direction.
- Write your recovery script for the moment you go blank: restate the question, state your assumption, name the first thing you would check.
- Reduce the week to the rule statements you wrote, each with its preconditions attached, then say every one of them out loud without reading it and cut any you cannot state in a single sentence, since a rule you have to reconstruct mid-answer will not survive being interrupted.
Deliverable: A one-page card holding the recovery script and only the rules you could state from memory.
Practice prompt ↗Practice prompt ↗Worked solution ↗Expand any day for tasks and deliverables. Your progress is saved on this device.
An answer without a quantity is hard to interrogate, so interviewers keep probing until they find one. Come with the baseline, the change, the window it was measured over, and how confident you were. If the effect never got measured, say so and say what you would have measured. Fabricated precision is worse than an honest gap.
Tell me about a time when you faced a significant challenge in a proje…
Tell me about a time when you faced a significant challenge in a project. How did you overcome it?
Approach
- Pick a story where you drove the decision, not one where you observed it.
- State the situation in two sentences and spend the rest on your reasoning.
- Quantify the outcome, including what you would not claim credit for.
Follow-up
- What did you decide not to do, and why?
- How did you know the outcome was caused by your change?
Describe a situation where you had to persuade others to accept your d…
Describe a situation where you had to persuade others to accept your data-driven recommendations.
Approach
- Pick a story where you drove the decision, not one where you observed it.
- Name the disagreement or constraint, and how you resolved it with evidence.
- Quantify the outcome, including what you would not claim credit for.
Follow-up
- What did you decide not to do, and why?
- How did you know the outcome was caused by your change?
Defend a null result against a programme sponsor
A care management programme enrolled the top 1 percent of members by prior-year allowed spend. The sponsor's deck shows allowed PMPM for enrollees falling 34 percent from the year before enrollment to the year after, and asks for budget to triple the programme. You rebuild the evaluation with a concurrent comparison group selected by the identical spend rule in the same period. The difference-in-differences estimate is a 3 percent reduction with a confidence interval spanning zero. Deliverable: how you present this, to whom, in what order, and what you propose next.
Approach
- Name the probe: whether you can deliver a finding that costs somebody their programme without softening it into uselessness or creating an adversary who routes around you next time.
- Lead with the mechanism, not the verdict. Show the comparison group's own unadjusted drop, which will be large, because a cohort selected on an extreme of the outcome regresses toward the mean whether or not anyone intervenes. The sponsor's 34 percent is mostly that, and it is a property of the selection rule rather than a criticism of their clinicians.
- Give the sponsor the finding privately before it appears in any deck their leadership sees. Being surprised in a room is what turns a methods disagreement into a political one.
- State the estimate with its interval and say what it rules out as well as what it fails to establish. A 3 percent point estimate whose interval crosses zero is not evidence of no effect; it is insufficient power to separate a modest effect from none, and those are different claims.
- Arrive with a design rather than only an objection. Propose a regression discontinuity at the enrollment threshold if the rule is applied sharply, or a randomised rollout across the next wave of eligible members, and state the sample size needed to detect the effect size the sponsor believes in.
Follow-up
- The sponsor says withholding the programme from a comparison group is unethical. What do you propose instead?
- Leadership wants one number for the board next week. What do you give them?
- What result would change your mind and make you believe the 34 percent?
- 01
Tell me about a time when you faced a significant challenge in a project. How did you overcome it?
- 02
Describe a situation where you had to persuade others to accept your data-driven recommendations.
- 03
A care management programme enrolled the top 1 percent of members by prior-year allowed spend. The sponsor's deck shows allowed PMPM for enrollees falling 34 percent from the year before enrollment to the year after, and asks for budget to triple the programme. You rebuild the evaluation with a concurrent comparison group selected by the identical spend rule in the same period. The difference-in-differences estimate is a 3 percent reduction with a confidence interval spanning zero. Deliverable: how you present this, to whom, in what order, and what you propose next.
Is this an official KARL STORZ interview guide?
No. It is PracHub's own research and practice material for the Data Scientist role at KARL STORZ. Rounds and questions reflect what candidates have reported, not a process KARL STORZ has published, and they change over time. Confirm the current format and scope with your recruiter.
PracHub interview research ↗How difficult are the interviews for the Data Scientist position?
The interviews are moderately challenging, focusing on both technical knowledge and cultural fit. Candidates should expect to prepare thoroughly for both types of questions.
PracHub interview research ↗What differentiates successful candidates at KARL STORZ?
Successful candidates demonstrate strong technical skills, effective communication, and a genuine alignment with the company’s mission to improve healthcare outcomes.
PracHub interview research ↗What is the typical timeline from the initial screen to the offer?
The process generally takes 4-6 weeks, depending on scheduling and the number of candidates being considered.
PracHub interview research ↗Is remote work an option for this position?
Typically, roles at KARL STORZ offer a hybrid work model, allowing for a mix of remote and in-office work. Candidates should confirm specifics during the interview process.
PracHub interview research ↗Sources & methodology 3 sources ↗
No official company page is cited. Rounds and questions come from candidate reports and PracHub editorial material; each source shows the date it was read.
- 01PracHub interview research ↗
PracHub editorial research into this company and role, maintained with this guide. Candidate-reported, not an employer publication.
PracHub page · Accessed 2026-09-22 - 02PracHub Data Scientist practice ↗
Cross-company practice questions for this role.
PracHub page · Accessed 2026-09-22 - 03PracHub interview preparation framework ↗
The framework the preparation plan follows.
PracHub page · Accessed 2026-09-22
Explore related engineering environments and compare the preparation focus.
Veracyte Data Scientist Interview Questions & Guide 2026
Causal-inference exercises for Veracyte data scientist prep: difference-in-differences, matching, instrumental variables, and knowing when observational data simply cannot answer the question asked.
Zoetis Data Scientist Interview Questions & Guide 2026
Metric-diagnosis practice for Zoetis data scientist candidates: a number moves week over week and you work out why, splitting by segment, ruling out a logging or release change, and separating a mix shift from a real change in user behaviou
Vizient Data Scientist Interview Questions & Guide 2026
Communication practice for Vizient data scientist candidates: turn an analysis into a recommendation, name the uncertainty honestly, and answer the follow-up a skeptical stakeholder will raise.
Vibrant Emotional Health Data Scientist Interview Questions & Guide 2026
Case practice for the Vibrant Emotional Health data scientist interview, where the prompt is deliberately underspecified and your first move is scoping it into something measurable.